GSK (GLAXF) Payments of Debt: $-2,101 Mil (TTM As of Mar. 2026)


GLAXF GSK PLC GLAXF
75 GF Score
Price $25.33
GF Value $21.09
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Payments of Debt?

GSK GLAXF 75 Payments of Debt is $-2,101 Mil as of Mar. 2026. GuruFocus rates GLAXF with a GF Score™ of 75/100 and a GF Value™ of $21.09 (Modestly Overvalued). The stock has 1 warning sign investors should review.

GSK's Payments of Debt for the three months ended in Mar. 2026 was $-27 Mil.

GSK's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-2,101 Mil.

GSK Payments of Debt Historical Data

* Premium members only.

The historical data trend for GSK's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Payments of Debt Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,063.83 -8,121.80 -3,282.28 -3,169.41 -2,259.71

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -205.43 -2,061.06 -8.11 -5.36 -26.67
GLAXF
75GF Score
GSK PLC GLAXF
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2,101 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-2,101 Mil mean?
GSK (GLAXF) has a Payments of Debt of $-2,101 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on GSK and its competitors.
Is GSK's Payments of Debt too high?
GSK's current Payments of Debt is $-2,101 Mil. Overall, GSK has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Payments of Debt compare to LLY and JNJ?
GSK's Payments of Debt of $-2,101 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on GSK and its competitors. GSK's current Payments of Debt is $-2,101 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (GLAXF) is currently considered Modestly Overvalued. The stock's GF Value™ is $21.09, compared to a current price of $25.33 — trading 20.1% above its estimated fair value. The current Payments of Debt is $-2,101 Mil. GSK's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For GSK (GLAXF), the current Payments of Debt is $-2,101 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (GLAXF) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of $25.33 is trading 20.1% above its estimated GF Value™ of $21.09. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for GLAXF:

  • Payments of Debt: $-2,101 Mil
  • GF Value™: $21.09 vs. price of $25.33 (20.1% above fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the GLAXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
75GF Score

Get the complete analysis for GLAXF

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.33
Price
$21.09
GF Value